Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi She Rong Pill in Cervical Spondylotic Myelopathy (Phase II)
CTR20210406Phase 2Completed
- Sponsor
- Shanghai Hutchison Pharmaceuticals Ltd.
- Start
- Mar 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shenqi Sherong Pill in cervical spondylomyelopathy (CSM), sponsored by Shanghai Hutchison Pharmaceuticals Ltd.. Started Mar 2021; status: completed.
02
Drugs
Shenqi Sherong Pill
03
Conditions
cervical spondylomyelopathy (CSM)
Beyond the preview
Go deeper on CTR20210406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210406.